Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Feb;28(2):190-5.
doi: 10.1136/gut.28.2.190.

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species

Y Miyachi et al. Gut. 1987 Feb.

Abstract

The relative in vitro anti-oxidant efficacy of sulphasalazine (salicylazosulphapyridine, SASP) and its metabolites (5-aminosalicylic acid, 5-ASA; sulphapyridine, SP) was examined by studying their effects on the generation of reactive oxygen species (ROS) using zymosan-stimulated polymorphonuclear leucocytes (PMNs) and a cell free, xanthine-xanthine oxidase system. Salicylazosulphapyridine, 5-ASA, and SP showed anti-oxidant effects to the various degrees. In particular, production of OH, which is one of the most potent reactive oxygen species, was remarkably suppressed by 5-ASA dose relatedly. These findings suggest that SASP and its metabolites play an important role in the inhibition of respiratory bursts. As the potent products of the respiratory burst by polymorphonuclear leucocytes are thought to be important inflammatory mediators, suppression of toxic reactive oxygen species generation by these agents may partly explain the therapeutic efficacy of SASP in ulcerative colitis, which is characterised by an acute mucosal inflammation dominated by polymorphonuclear leucocytes accumulation.

PubMed Disclaimer

References

    1. Lancet. 1978 Nov 4;2(8097):993 - PubMed
    1. Gut. 1978 Oct;19(10):875-7 - PubMed
    1. Gut. 1979 Sep;20(9):802-5 - PubMed
    1. Acta Med Scand. 1979;206(6):451-7 - PubMed
    1. Biochem Pharmacol. 1980 Feb 15;29(4):533-8 - PubMed